Veradigm Inc. Reminder: Robbins LLP is Investigating MDRX on Behalf of Investors

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (NASDAQ: MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders. Veradigm is a healthcare technology company that provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

What Now: Veradigm Inc. shareholders have legal options. If you own shares of Veradigm Inc. and have lost money in your investment, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Aaron Dumas, Jr.
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Veradigm Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:MDRX

Release Summary

Veradigm Inc. Reminder: Robbins LLP is Investigating MDRX on Behalf of Investors

Release Versions

$Cashtags

Hashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles

Robbins LLP

More News From Robbins LLP

Hertz Global Holdings, Inc. (NASDAQ: HTZ) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons who purchased or otherwise acquired Hertz Global Holdings, Inc. (NASDAQ: HTZ) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should contact Robbins LLP for information about becoming lead plaintiff.Why Was Her...

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock between February 28, 2024 and February 25, 2026, inclusive (the "Class Period").Investors who suffered significant losses during the Class Period may be eligible to participate in the lawsuit and should contact Robbins LLP for information about becoming lead plaintiff.Why Was PROCEPT Sued?The complaint a...

Robbins LLP Informs Pentair plc (PNR) Investors of Ongoing Investigation

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Pentair plc (NYSE: PNR) to determine whether certain Pentair plc officers and directors violated securities laws and breached fiduciary duties to shareholders. Pentair plc provides various water solutions in the United States, Western Europe, China, Latin America, the Middle East, Southeast Asia, Australia, and Canada.On April 28, 2026, Pentair projected that second-quarter sales would increase approximately 1%...

Back to Newsroom